Search

Search Constraints

You searched for: Author/Creator Finch, Daygen

Search Results

1. Clinical effectiveness of docetaxel for castration‐sensitive prostate cancer in a real‐world population‐based analysis. Issue 3 (28th October 2018)

2. Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial. Issue 12 (December 2020)

3. Effectiveness of first-line abiraterone versus enzalutamide among patients ≥80 years of age with metastatic castration-resistant prostate cancer: A retrospective propensity score–weighted comparative cohort study. (July 2021)

4. Final report of a phase 2 clinical trial of lenalidomide monotherapy for patients with T‐cell lymphoma. Issue 5 (29th October 2014)